WST 51.32 West Pharmaceutical Services $WST Hit a 52 week

New Post Public Reply Private Reply Replies (0) Message Board

Nov 12, 2014 at 3:29 PM

WST 51.32 West Pharmaceutical Services $WST Hit a 52 week high of 51.37 Closing the day 09:45 at 51.32 -0.14 -0.27% With a day low of 51.12 and a total volume of 6,054.

WST Recent Posts: http://investorshangout.com/West-Pharmaceutic...WST-53126/

WST West Pharmaceutical Services Recent Headline News

Uptrend Call Working As West Pharmaceutical Services Stock Rises 20.5% (WST)
Comtex SmarTrend(R) - Wed Nov 12, 11:07AM CST
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on August 18th, 2014 at $42.47. In approximately 3 months, West Pharmaceutical Services has returned 20.46% as of today's recent price of $51.16.
WST: 51.99 (+0.53)

West wins US FDA clearance for NovaGuard SA Safety System to help reduce risk of needlestick injury to healthcare workers and patients
M2 - Wed Nov 12, 7:07AM CST
Injectable drug company West Pharmaceutical Services (NYSE:WST) reported on Tuesday the receipt of the 510(k) clearance from the US Food and Drug Administration for its NovaGuard SA (Staked-needle Automatic) safety system.
WST: 51.97 (+0.51)

After Yesterday's Rally of 2.22% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Nov 11, 5:00PM CST
West Pharmaceutical Services (NYSE:WST) traded in a range yesterday that spanned from a low of $50.50 to a high of $52.14. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $51.10 on volume of 661,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
WST: 51.97 (+0.51)

West Receives 510(k) Clearance for NovaGuard(TM) SA Safety System
PR Newswire - Tue Nov 11, 7:00AM CST
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the NovaGuard SA (Staked-needle Automatic) safety system has received 510(k) clearance from the United States Food and Drug Administration. The NovaGuard SA safety system helps reduce the risk of needlestick injuries by shielding the exposed needle of a prefilled syringe after use.
WST: 51.97 (+0.51)

Shares of WST Up 20.4% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Nov 05, 9:43AM CST
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on August 18th, 2014 at $42.47. In approximately 3 months, West Pharmaceutical Services has returned 20.37% as of today's recent price of $51.12.
WST: 51.97 (+0.51)

West Pharmaceuticals: A Little Giant In The Pharma Sector
Bill Gunderson - Seeking Alpha - Mon Nov 03, 9:26AM CST
West Pharmaceutical Services ( WST ) is an example of a good stock in a good sector. I like the health care sector in the current market environment but I prefer companies that are growing at a faster pace than the Eli Lillys ( LLY ) and Mercks ( ...
WST: 51.97 (+0.51), MRK: 59.30 (-0.07), LLY: 67.64 (-0.21)

West Pharmaceutical Services Larger Than S&P 500 Component Allegheny Technologies
TheOnlineInvestor.com - Thu Oct 30, 3:43PM CDT
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component West Pharmaceutical Services, Inc. was identified as having a larger market cap than the smaller end of the S&P 500, for example Allegheny...
WST: 51.97 (+0.51)

West Pharmaceutical Services' (WST) CEO Don Morel on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 12:27PM CDT

WST: 51.97 (+0.51)

West Pharmaceutical Services (WST) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 7:55AM CDT

WST: 51.97 (+0.51)

West Pharmaceutical beats by $0.01, revenue in-line
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 6:16AM CDT

WST: 51.97 (+0.51)

West Pharmaceutical posts 3Q profit
Automated Insights - Thu Oct 30, 6:10AM CDT
LIONVILLE, Pa. (AP) _ West Pharmaceutical Services Inc. (WST) on Thursday reported net income of $31 million in its third quarter.
WST: 51.97 (+0.51)

West Announces Third Quarter 2014 Results
Marketwired - Thu Oct 30, 6:02AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter of 2014 and updated its revenue and gross margin guidance for 2014 and its long-term financial objectives.
WST: 51.97 (+0.51)

West Pharmaceutical Services Shares Up 13.0% Since SmarTrend's Buy Recommendation (WST)
Comtex SmarTrend(R) - Wed Oct 29, 9:23AM CDT
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on August 18th, 2014 at $42.47. In approximately 2 months, West Pharmaceutical Services has returned 12.97% as of today's recent price of $47.98.
WST: 51.97 (+0.51)

West Pharmaceuticals In Q3: The Cure For What Ails You?
Kurt Avard - at Seeking Alpha - Tue Oct 28, 12:38PM CDT

WST: 51.97 (+0.51)

The Week Ahead In Earnings Reports: Pharmaceuticals
Kurt Avard - at Seeking Alpha - Sat Oct 25, 4:32PM CDT

WST: 51.97 (+0.51), PFE: 30.45 (+0.13), MRK: 59.30 (-0.07)

West Pharma Services reports October 30
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 12:22PM CDT

WST: 51.97 (+0.51)

West to Host Third Quarter 2014 Conference Call
Marketwired - Thu Oct 23, 7:01AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today that it will release third quarter 2014 financial results before the market opens on Thursday, October 30, 2014 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 877-280-4960 (U.S.) or 857-244-7317 (International). The passcode is 46283848.
WST: 51.97 (+0.51)

West's Vial2Bag DC Device Receives U.S. FDA 510(k) Clearance and CE Mark
PR Newswire - Tue Oct 21, 7:00AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, has received 510(k) clearance of the Vial2Bag® DC device from the United States Food and Drug Administration, and also the CE Mark for the European Union.
WST: 51.97 (+0.51)

Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Monday: GAIN, GOOD, WST
at The Street - Fri Oct 17, 9:03AM CDT
GAIN GOOD WST are going ex-dividend Monday, Monday, October 20, 2014
WST: 51.97 (+0.51), GOOD: 18.04 (-0.06), GAIN: 7.31 (unch)

West Pharmaceutical CEO to retire next year
AP - Wed Oct 15, 8:50AM CDT
NEW YORK (AP) — West Pharmaceutical Services Inc. said Wednesday that its longtime CEO Donald Morel plans to retire in May. The company, which makes syringes, medicine vials and other medical products, also narrowed its earnings outlook for the year.
WST: 51.97 (+0.51)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Hit with Legal Scrutiny After Disappointing Q2

D-Wave Quantum Under Legal Microscope Alright, folks, let's dive headfirst into some dicey financial waters with D-Wave Quantum Inc. (NASDAQ: QBTS). This quantum computing company is finding itself in a bit of a pickle following some rough second-quarter results that left investors scratching their heads. If you bought into the hype and are feeling the sting in your...

Morpho Unveils Versatile UV Printer at IFA 2026

IFA 2026: A New Frontier for Desktop Printing You've seen your fair share of printers over the years, but when a company like Morpho steps onto the scene with a gadget that echoes innovation, it makes you perk up those market-ears. We're talking the big unveil of their desktop UV printer at the IFA 2026 in Berlin. Morpho's contraption isn't just spewing out ink; it's...

Media Forum Spotlights Asia-Pacific Cooperation

The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...

EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Zendure, SolarFlow Pro Win Big at IFA 2026 Tech Awards

Trophy Time for Zendure in Berlin The Berlin Chronicles of 2026 tell an interesting tale for Zendure—a tale where top honors and glowing recognition highlight its efforts in the sustainable energy arena. At the Global Product Technology Innovation Awards, Zendure's SolarFlow 4000 Mix Pro snagged the Gold for Sustainable Home Energy Storage System. Not only that, but...

FDI Launches 'Generation Smile' for Global Oral Health

A New Kind of Movement Imagine a campaign not bound by age or geography but united by a shared mission. Generation Smile, freshly launched by the FDI World Dental Federation in Prague, is just that kind of uprising. This initiative redefines existing approaches to oral health, pushing beyond the boundaries of mere dental care to emphasize the integral role oral health...

Asia-Pacific Media Forum Eyes Future Growth Strategies

Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...

TECNO's Modular Phone and Mini-PC Win Big at IFA 2026

The Tale of Two Game-Changers TECNO has just scooped up two big-time awards, and I'm here to break it down like no glossy magazine ever could. Picture this: a brand that knows how to keep its foot on the innovation pedal and doesn't shy away from shaking up the tech world. TECNO's got the goods, claiming two prestigious IFA Global Product Technology Innovation Awards this...

DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Midea's VitaBreeze: Revolutionizing Personalized Climate

A Fresh Breeze in Climate Control Here's something that'll shake up your household. Midea just announced their latest gizmo, called VitaBreeze, and they’re not messing around. They introduced it at IFA 2026, promising it's not just for cooling off in the summer or heating in the winter. Oh no, my friends, they've packed this unit with enough cutting-edge tech that...